Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Drug Delivery"
DOI: 10.1080/17425247.2018.1407755
Abstract: ABSTRACT Background: For interferon beta-1a subcutaneously three times weekly (IFN β-1a SC tiw), administration options include manually injected prefilled syringes; a preassembled, single-use autoinjector; and a reusable autoinjector. This study evaluated patient-perceived ease of use… read more here.
Keywords: use; autoinjector; use two; interferon beta ... See more keywords